Trial record 1 of 1 for:    NCT00991029
Previous Study | Return to List | Next Study

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

This study is currently recruiting participants.
Verified February 2014 by University of California, San Francisco
Sponsor:
Collaborators:
Neurological Emergencies Treatment Trials Network (NETT)
Medical University of South Carolina
The EMMES Corporation
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00991029
First received: October 6, 2009
Last updated: February 3, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)
No publications provided by University of California, San Francisco

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):